PT - JOURNAL ARTICLE AU - J. Lelieveld AU - F. Helleis AU - S. Borrmann AU - Y. Cheng AU - F. Drewnick AU - G. Haug AU - T. Klimach AU - J. Sciare AU - H. Su AU - U. Pöschl TI - Model Calculations of Aerosol Transmission and Infection Risk of COVID-19 in Indoor Environments AID - 10.1101/2020.09.22.20199489 DP - 2020 Jan 01 TA - medRxiv PG - 2020.09.22.20199489 4099 - http://medrxiv.org/content/early/2020/10/02/2020.09.22.20199489.short 4100 - http://medrxiv.org/content/early/2020/10/02/2020.09.22.20199489.full AB - The role of aerosolized SARS-CoV-2 viruses in airborne transmission of COVID-19 is debated. The transmitting aerosol particles are generated through the breathing and vocalization by infectious subjects. Some authors state that this represents the dominant route of spreading, while others dismiss the option. Public health organizations generally categorize it as a secondary transmission pathway. Here we present a simple, easy-to-use spreadsheet model to estimate the infection risk for different indoor environments, constrained by published data on human aerosol emissions, SARS-CoV-2 viral loads, infective dose and other parameters. We evaluate typical indoor settings such as an office, a classroom, a choir practice room and reception/party environments. These are examples, and the reader is invited to use the algorithm for alternative situations and assumptions. Our results suggest that aerosols from highly infective subjects can effectively transmit COVID-19 in indoor environments. This “highly infective” category represents approximately twenty percent of the patients tested positive for SARS-CoV-2. We find that “super infective” subjects, representing the top five to ten percent of positive-tested ones, plus an unknown fraction of less, but still highly infective, high aerosol-emitting subjects, may cause COVID-19 clusters (>10 infections), e.g. in classrooms, during choir singing and at receptions. The highly infective ones also risk causing such events at parties, for example. In general, active room ventilation and the ubiquitous wearing of face masks (i.e. by all subjects) may reduce the individual infection risk by a factor of five to ten, similar to high-volume HEPA air filtering. The most effective mitigation measure studied is the use of high-quality masks, which can drastically reduce the indoor infection risk through aerosols.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis study used published data in the analysis.Funding StatementMax Planck Society.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in the analysis are provided in the manuscript and supplementary materials.